3,5-Dimethylphenylboronic acid | CAS:172975-69-8

We serve 3,5-Dimethylphenylboronic acid CAS:172975-69-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3,5-Dimethylphenylboronic acid

Product Name: 3,5-Dimethylphenylboronic acid
Other Name:
3,5-Dimethylphenylboronic acid
3,5-Dimethylbenzeneboronic Acid
(3,5-dimethylphenyl)boronic acid
m-Xylene-5-boronic Acid
3,5-Dimethylphenylboron
CAS No: 172975-69-8
MF: C8H11BO2
MW: 149.98300
Density: 1.07 g/cm3
Boiling point: 312.7ºC at 760 mmHg
Melting point: 261-265 °C(lit.)
Flash point: 142.9ºC
UN Number: Not dangerous goods.
Transport hazard class: Not dangerous goods.
Packing group: Not dangerous goods.
 
Specification
Appearance: White powder
Assay: ≥98.0%
Water: ≤0.50%
 
Application
Be used as pharmaceutical intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like 3,5-Dimethylphenylboronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3,5-Dimethylphenylboron physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(3,5-dimethylphenyl)boronic acid Use and application,m-Xylene-5-boronic Acid technical grade,usp/ep/jp grade.


Related News: Saudi Arabia’s state airline and Oman also suspended flights to China on Sunday in reaction to the coronavirus epidemic, according to Reuters.o-Toluoyl chloride manufacturer Saudi Arabia’s state airline and Oman also suspended flights to China on Sunday in reaction to the coronavirus epidemic, according to Reuters.Methyl N-(2-chlorophenyl)glycinate hydrochloride (1:1) supplier Saudi Arabia’s state airline and Oman also suspended flights to China on Sunday in reaction to the coronavirus epidemic, according to Reuters.Thioacetic acid vendor In the first round of nationwide implement of the program, in September, multinationals including Sanofi and Eli Lilly managed to cut some prices low enough to levels close to those offered by local generic makers.In the first round of nationwide implement of the program, in September, multinationals including Sanofi and Eli Lilly managed to cut some prices low enough to levels close to those offered by local generic makers.